{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:14:33Z","timestamp":1791328473177,"version":"4.3.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["jdsjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.jdermsci.2014.04.005","type":"journal-article","created":{"date-parts":[[2014,4,16]],"date-time":"2014-04-16T00:46:32Z","timestamp":1397609192000},"page":"43-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Induction of cytotoxic T cells as a novel independent survival factor in malignant melanoma with percutaneous peptide immunization"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3612-8025","authenticated-orcid":false,"given":"Toshiharu","family":"Fujiyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Oze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Hashizume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keitaro","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Hino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riei","family":"Kamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Imayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Hirakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisuke","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Takigawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Tokura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2014.04.005_bib0005","article-title":"Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic","volume":"214","author":"Morton","year":"1991","journal-title":"Ann Surg"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0010","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1038\/jid.2008.101","article-title":"Immunotherapy for advanced melanoma","volume":"128","author":"Fang","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0015","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/pcmr.12111","article-title":"T cell immunotherapy for melanoma from bedside to bench to barn and back: how conceptual advances in experimental mouse models can be translated into clinical benefit for patients","volume":"26","author":"Tuting","year":"2013","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0020","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1200\/JCO.2011.38.0899","article-title":"Cancer immunotherapy comes of age","volume":"29","author":"Topalian","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0025","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nature06309","article-title":"Adaptive immunity maintains occult cancer in an equilibrium state","volume":"450","author":"Koebel","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0030","doi-asserted-by":"crossref","first-page":"6375","DOI":"10.1073\/pnas.94.12.6375","article-title":"Mutated mitogen-activated protein kinase: a tumor rejection antigen of mouse sarcoma","volume":"94","author":"Ikeda","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0035","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1126\/science.1840703","article-title":"A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma","volume":"254","author":"van der Bruggen","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0040","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.7652577","article-title":"A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma","volume":"269","author":"Wolfel","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0045","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0167-5699(95)80125-1","article-title":"Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy?","volume":"16","author":"Grabbe","year":"1995","journal-title":"Immunol Today"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0050","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(06)90001-7","article-title":"Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity","volume":"90","author":"Smyth","year":"2006","journal-title":"Adv Immunol"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0060","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1146\/annurev.immunol.22.012703.104803","article-title":"The three Es of cancer immunoediting","volume":"22","author":"Dunn","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0065","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.immuni.2013.07.004","article-title":"Dendritic-cell-based therapeutic cancer vaccines","volume":"39","author":"Palucka","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0070","doi-asserted-by":"crossref","first-page":"10136","DOI":"10.1158\/0008-5472.CAN-06-1029","article-title":"Induction of therapeutically relevant cytotoxic T lymphocytes in humans by percutaneous peptide immunization","volume":"66","author":"Yagi","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0075","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1073\/pnas.97.1.371","article-title":"Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis","volume":"97","author":"Seo","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0080","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.4049\/jimmunol.167.6.3276","article-title":"Crystal structures of two closely related but antigenically distinct HLA-A2\/melanocyte-melanoma tumor-antigen peptide complexes","volume":"167","author":"Sliz","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0085","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1200\/JCO.1983.1.11.710","article-title":"Analysis of survival by tumor response","volume":"1","author":"Anderson","year":"1983","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0090","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1755-148X.2010.00736.x","article-title":"Dendritic cell vaccination in human melanoma: relationships between clinical effects and vaccine parameters","volume":"23","author":"Nakai","year":"2010","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0095","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5","article-title":"Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma","volume":"77","author":"Clemente","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0100","first-page":"43","article-title":"Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response","volume":"74","author":"Mihm","year":"1996","journal-title":"Lab Invest"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0105","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00005-007-0029-3","article-title":"Tumor resistance to CD8+ T cell-based therapeutic vaccination","volume":"55","author":"Huang","year":"2007","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0110","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1084\/jem.182.1.261","article-title":"T cell priming versus T cell tolerance induced by synthetic peptides","volume":"182","author":"Aichele","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0115","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1126\/science.280.5361.243","article-title":"Homeostasis and self-tolerance in the immune system: turning lymphocytes off","volume":"280","author":"Van Parijs","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0120","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nri821","article-title":"CD4+ CD25+ suppressor T cells: more questions than answers","volume":"2","author":"Shevach","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0125","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1365-2567.2001.01279.x","article-title":"Interleukin-10 expressed at early tumour sites induces subsequent generation of CD4(+) T-regulatory cells and systemic collapse of antitumour immunity","volume":"103","author":"Seo","year":"2001","journal-title":"Immunology"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0130","first-page":"1927","article-title":"Resistance to lysis by cytotoxic T cells: a dominant effect in metastatic mouse prostate cancer cells","volume":"60","author":"Lee","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0135","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/cncr.24899","article-title":"Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma","volume":"116","author":"Hino","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0140","doi-asserted-by":"crossref","first-page":"e53131","DOI":"10.1371\/journal.pone.0053131","article-title":"Inhibition of IL-17A in tumor microenvironment augments cytotoxicity of tumor-infiltrating lymphocytes in tumor-bearing mice","volume":"8","author":"Hayata","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0145","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1158\/1078-0432.CCR-04-0260","article-title":"On the role of melanoma-specific CD8+ T-cell immunity in disease progression of advanced-stage melanoma patients","volume":"10","author":"van Oijen","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0150","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.immuni.2005.10.008","article-title":"Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity","volume":"23","author":"Kaplan","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0155","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.immuni.2005.04.004","article-title":"Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells","volume":"22","author":"Kissenpfennig","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0160","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.4049\/jimmunol.180.3.1991","article-title":"Tumor immunotherapy by epicutaneous immunization requires langerhans cells","volume":"180","author":"Stoitzner","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0165","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.0105-2896.2009.00886.x","article-title":"Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin","volume":"234","author":"Romani","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0170","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.imlet.2007.01.007","article-title":"Initiation of adaptive immune responses by transcutaneous immunization","volume":"109","author":"Warger","year":"2007","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0175","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1016\/S0264-410X(00)00507-7","article-title":"The bare skin and the nose as non-invasive routes for administering peptide vaccines","volume":"19","author":"Partidos","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.jdermsci.2014.04.005_bib0180","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cellimm.2010.09.003","article-title":"Transcutaneous immunization with hydrophilic recombinant gp100 protein induces antigen-specific cellular immune response","volume":"266","author":"Eisenberg","year":"2010","journal-title":"Cell Immunol"}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181114000851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181114000851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T11:33:55Z","timestamp":1565350435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181114000851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0923181114000851"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2014.04.005","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction of cytotoxic T cells as a novel independent survival factor in malignant melanoma with percutaneous peptide immunization","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2014.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}